120 related articles for article (PubMed ID: 37282642)
21. BRD4 promotes the stemness of gastric cancer cells via attenuating miR-216a-3p-mediated inhibition of Wnt/β-catenin signaling.
Song H; Shi L; Xu Y; Xu T; Fan R; Cao M; Xu W; Song J
Eur J Pharmacol; 2019 Jun; 852():189-197. PubMed ID: 30876979
[TBL] [Abstract][Full Text] [Related]
22. [Expression of BRD4 in squamous cell carcinoma and its effects on cell proliferation and invasion ability].
Gao XZ; Li WC; Diao CY; Wang XH; Li SL
Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):344-348. PubMed ID: 29783800
[No Abstract] [Full Text] [Related]
23. Downregulation of BRD4 attenuates high glucose-induced damage of trophoblast cells by inhibiting activation of AKT/mTOR pathway.
Chai O; Tang N; Guo R; Cui D; Hou Z
Reprod Biol; 2023 Jun; 23(2):100751. PubMed ID: 36871542
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-4651 targets bromodomain-containing protein 4 to inhibit non-small cell lung cancer cell progression.
Zheng J; Zhang Y; Cai S; Dong L; Hu X; Chen MB; Zhu YH
Cancer Lett; 2020 Apr; 476():129-139. PubMed ID: 32081805
[TBL] [Abstract][Full Text] [Related]
25. Regulation of the
Gu P; Huang W; Lu W; Shu P
Discov Med; 2024 May; 36(184):923-935. PubMed ID: 38798252
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effect of microRNA-608 on lung cancer cell proliferation, migration, and invasion by targeting BRD4 through the JAK2/STAT3 pathway.
Xu W; Sun D; Wang Y; Zheng X; Li Y; Xia Y; Teng Y
Bosn J Basic Med Sci; 2020 Aug; 20(3):347-356. PubMed ID: 31621555
[TBL] [Abstract][Full Text] [Related]
27. BRD4 promotes tumor growth and epithelial-mesenchymal transition in hepatocellular carcinoma.
Zhang P; Dong Z; Cai J; Zhang C; Shen Z; Ke A; Gao D; Fan J; Shi G
Int J Immunopathol Pharmacol; 2015 Mar; 28(1):36-44. PubMed ID: 25816404
[TBL] [Abstract][Full Text] [Related]
28. DSC2 Suppresses the Metastasis of Gastric Cancer through Inhibiting the BRD4/Snail Signaling Pathway and the Transcriptional Activity of
Sun C; Wang L; Du DD; Ji JB; Yang XX; Yu BF; Shang PF; Guo XL
Oxid Med Cell Longev; 2022; 2022():4813571. PubMed ID: 36120591
[TBL] [Abstract][Full Text] [Related]
29. Expression and prognosis of MYOZ2 in gastric cancer.
Li YF; Zhu GY; Ma Y; Qu HY
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5920-5927. PubMed ID: 30280773
[TBL] [Abstract][Full Text] [Related]
30. Caveolin-2 is regulated by BRD4 and contributes to cell growth in pancreatic cancer.
Jiao F; Han T; Yuan C; Liang Y; Cui J; Zhuo M; Wang L
Cancer Cell Int; 2020; 20():55. PubMed ID: 32099528
[TBL] [Abstract][Full Text] [Related]
31. [Effect of miR-204-5p on the proliferation, migration, and invasion on tongue squamous cell carcinoma SCC25 cells by targeting bromodomain-containing protein 4].
Zheng J; Zhang YW; Li TK; Bao Y; Zhang SX
Hua Xi Kou Qiang Yi Xue Za Zhi; 2020 Apr; 38(2):185-192. PubMed ID: 32314893
[TBL] [Abstract][Full Text] [Related]
32. circCELSR1 facilitates ovarian cancer proliferation and metastasis by sponging miR-598 to activate BRD4 signals.
Zeng XY; Yuan J; Wang C; Zeng D; Yong JH; Jiang XY; Lan H; Xiao SS
Mol Med; 2020 Jul; 26(1):70. PubMed ID: 32640974
[TBL] [Abstract][Full Text] [Related]
33. Methylation-silencing RCC1 expression is associated with tumorigenesis and depth of invasion in gastric cancer.
Lin YL; Chen HL; Cheng SB; Yeh DC; Huang CC; P'eng FK; Tsai TC; Wu CC; Chen CM
Int J Clin Exp Pathol; 2015; 8(11):14257-69. PubMed ID: 26823742
[TBL] [Abstract][Full Text] [Related]
34. Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer.
Zhang W; Huang L; Lu X; Wang K; Ning X; Liu Z
Bosn J Basic Med Sci; 2019 May; 19(2):164-171. PubMed ID: 30821221
[TBL] [Abstract][Full Text] [Related]
35. Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer.
Faivre EJ; McDaniel KF; Albert DH; Mantena SR; Plotnik JP; Wilcox D; Zhang L; Bui MH; Sheppard GS; Wang L; Sehgal V; Lin X; Huang X; Lu X; Uziel T; Hessler P; Lam LT; Bellin RJ; Mehta G; Fidanze S; Pratt JK; Liu D; Hasvold LA; Sun C; Panchal SC; Nicolette JJ; Fossey SL; Park CH; Longenecker K; Bigelow L; Torrent M; Rosenberg SH; Kati WM; Shen Y
Nature; 2020 Feb; 578(7794):306-310. PubMed ID: 31969702
[TBL] [Abstract][Full Text] [Related]
36. Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4.
Villar-Prados A; Wu SY; Court KA; Ma S; LaFargue C; Chowdhury MA; Engelhardt MI; Ivan C; Ram PT; Wang Y; Baggerly K; Rodriguez-Aguayo C; Lopez-Berestein G; Ming-Yang S; Maloney DJ; Yoshioka M; Strovel JW; Roszik J; Sood AK
Mol Cancer Ther; 2019 Feb; 18(2):421-436. PubMed ID: 30420565
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of miR-329 promotes cell invasion by regulating BRD4 and predicts poor prognosis in hepatocellular carcinoma.
Zhou J; Li W; Guo J; Li G; Chen F; Zhou J
Tumour Biol; 2016 Mar; 37(3):3561-9. PubMed ID: 26456956
[TBL] [Abstract][Full Text] [Related]
38. Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer.
He LJ; Xie D; Hu PJ; Liao YJ; Deng HX; Kung HF; Zhu SL
World J Gastroenterol; 2015 Sep; 21(34):9916-26. PubMed ID: 26379396
[TBL] [Abstract][Full Text] [Related]
39. Expression and clinical value of PD-L1 which is regulated by BRD4 in tongue squamous cell carcinoma.
Zhao L; Li P; Zhao L; Wang M; Tong D; Meng Z; Zhang Q; Li Q; Zhang F
J Cell Biochem; 2020 Feb; 121(2):1855-1869. PubMed ID: 31633227
[TBL] [Abstract][Full Text] [Related]
40. BRD4 Regulates EZH2 Transcription through Upregulation of C-MYC and Represents a Novel Therapeutic Target in Bladder Cancer.
Wu X; Liu D; Tao D; Xiang W; Xiao X; Wang M; Wang L; Luo G; Li Y; Zeng F; Jiang G
Mol Cancer Ther; 2016 May; 15(5):1029-42. PubMed ID: 26939702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
